首页> 美国卫生研究院文献>AAPS PharmSciTech >Mucoadhesive thermosensitive prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex
【2h】

Mucoadhesive thermosensitive prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex

机译:用于克霉唑的粘膜粘附性热敏性阴道延长释放凝胶:β-环糊精复合物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study was to achieve a better therapeutic efficacy and patient compliance in the treatment for vaginitis. Clotrimazole (1%) has been formulated in a vaginal gel using the thermosensitive polymer Pluronic F127 (20%) together with mucoadhesive polymers such as Carbopol 934 and hydroxypropylmethylcellulose (0.2% for both). To increase its aqueous solubility., clotrimazole was incorporated as its inclusion complex with 1∶1 molar ratio with β-cyclodextrin. The inclusion complex was thoroughly characterized using various techniques, including 1H NMR spectroscopy, FT IR spectrophotometry, differential scanning calorimetry, scanning electron microscopy, phase solubility studies, and determination of stability constant (k1∶1). The gelation temperature and rheological behavior of different formulations at varying temperatures were measured. In vitro release profiles of the gels were determined in pH 5.5 citrate buffer. It was observed that complexation with cyclodextrin slowed down the release of clotrimazole considerably. Carbopol 934, on the other hand, was found to interact with β-cyclodextrin, inducing precipitation. As far as rheological properties are concerned, thermosensitive in situ gelling was obtained with formulations containing drug: cyclodextrin complex rather than with free drug. Thus, the optimum formulation for a controlled-release thermosensitive and mucoadhesive vaginal gel was determined to be clotrimazole: β-cyclodextrin 1% with 0.2% hydroxypropylmethylcellulose in Pluronic F127 gel (20%) providing continuous and prolonged release of active material above MIC values.
机译:这项研究的目的是在阴道炎的治疗中获得更好的疗效和患者依从性。克霉唑(1%)已在阴道凝胶中使用热敏聚合物Pluronic F127(20%)和粘膜粘附性聚合物(如Carbopol 934和羟丙基甲基纤维素(两者均为0.2%))配制而成。为了增加其水溶性,将克霉唑作为其包合物与β-环糊精以1∶1的摩尔比掺入。使用多种技术,包括 1 1H NMR光谱,FT IR分光光度法,差示扫描量热法,扫描电子显微镜,相溶解度研究和稳定性常数(k1∶1)的测定,对包合物进行了全面表征。测量了不同制剂在不同温度下的胶凝温度和流变行为。在pH 5.5柠檬酸盐缓冲液中测定凝胶的体外释放曲线。观察到与环糊精的络合大大降低了克霉唑的释放。另一方面,发现Carbopol 934与β-环糊精相互作用,诱导沉淀。就流变性质而言,使用含有药物:环糊精复合物而不是游离药物的制剂可获得热敏原位胶凝。因此,确定用于控释热敏性和粘膜粘着性阴道凝胶的最佳配方是克霉唑:在Pluronic F127凝胶(20%)中含有0.2%羟丙基甲基纤维素的1%β-环糊精,可提供超过MIC值的连续且延长的活性物质释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号